Local delivery of an active agent from an orthopedic implant

• US 20060247623A1
• Filed: 04/29/2005
• Published: 11/02/2006
• Est. Priority Date: 04/29/2005
• Status: Abandoned Application

• Current Assignee: Warsaw Orthopedic Incorporated (Medtronic Plc)
• Original Assignee: SDGI Holdings Incorporated (Medtronic Plc)
• Inventors: Bruneau, Aurelien, Lange, Eric C., Anderson, Kent M., Molz, Fred J. IV, Dewey, Jonathan, Morrison, Matthew M., Carls, Thomas
• Application Number:
  US11/117,891
• Publication Number:
  US 20060247623A1
• Time in Patent Office: Days
• US Class Current: 606/248
• CPC Class Codes: A61B 17/7001 Screws or hooks combined with longitudinal elements which do not contact vertebrae A61B17/7058 takes precedence
• CPC Class Codes: A61B 17/7031 made wholly or partly of flexible material
• CPC Class Codes: A61B 17/7062 Devices acting on, attached to, or simulating the effect of, vertebral processes, vertebral facets or ribs rib fixation devices A61B17/8076; Tools for such devices
• CPC Class Codes: A61B 2017/00004 (bio)absorbable, (bio)resorbable, resorptive for implantable prostheses A61F2210/0004

Abstract

A posterior spinal fixation device or dynamic spinal stabilization device or other orthopedic device includes an active agent-delivery component. The active agent-delivery component has an active agent impregnated therein or adsorbed thereon or otherwise contained therein and is configured to release the active agent locally after the device is implanted in a patient. One preferred type of implant in accordance with the invention is an implant for stabilizing a spinal motion segment that includes a spacer member positionable between adjacent spinous processes or transverse processes or other posterior spinal element, including an implanted anchor element.

Claims

1. A posterior spinal fixation device or dynamic spinal stabilization device comprising an active agent-delivery component, wherein said active agent-delivery component has an active agent impregnated therein or adsorbed thereon or otherwise contained therein and is configured to release the active agent locally after the device is implanted in a patient.

2. The device in accordance with claim 1 wherein said device is a dynamic stabilization device configured for placement between adjacent spinous processes, between adjacent transverse processes or between other posterior vertebral elements.

3. The device in accordance with claim 1 wherein said device is an inter-spinous process dynamic stabilization device or spinous process fixation device.

4. The device in accordance with claim 1 wherein said device is an inter-transverse process dynamic stabilization device.

5. The device in accordance with claim 1 wherein said device is an anchor-based stabilization or fixation system.

6. The device in accordance with claim 1 wherein said device comprises at least one structural component configured to provide spinal stabilization, and wherein at least a portion of at least one of said structural components has the active agent impregnated therein or adsorbed thereon.

7. The device in accordance with claim 6 wherein said device comprises an internal structural component contained within an outer sheath, and wherein said outer sheath comprises an absorbent or adsorbent or biodegradable material having said active agent impregnated therein or adsorbed thereon.

8. The device in accordance with claim 1 wherein said device comprises at least one structural component configured to provide spinal stabilization and at least one active agent-delivery component retained by said structural component.

9. The device in accordance with claim 8 wherein said device comprises an internal structural component positioned within an outer sheath, and wherein said active agent-delivery component comprises an absorbent or adsorbent or biodegradable layer positioned between the internal structural component and the outer sheath.

10. The device in accordance with claim 8 wherein said device has an exterior surface and wherein said active agent-delivery component comprises an active agent-delivery layer affixed to at least a portion of said exterior surface.

11. The device in accordance with claim 8 wherein said structural component defines at least one aperture and wherein said active agent-delivery component is an insert configured to be positioned in the aperture.

12. The device in accordance with claim 11 wherein said insert comprises a micromechanical machine.

13. The device in accordance with claim 1 wherein said active agent is selected from the group consisting of an anabolic agent, an anti-coagulant, an anti-infective agent, an anti-inflammatory agent, an anti-neoplastic agent, an anti-pyretic agent, an analgesic agent, an anti-spasmodic agent, an anti-thrombotic agent, an antihistamine, a biological, a bone morphogenetic protein, a diagnostic agent, a neuromuscular drug, a nutritional agent, a vasodilator, and a pro-drug.

14. The device in accordance with claim 1 wherein, after implantation of said device, said device releases said active agent in a sustained release manner.

15. The device in accordance with claim 1 wherein said active agent-delivery component comprises an elastic material having said active agent absorbed therein or adsorbed thereon.

16. The device in accordance with claim 15 wherein said device is configured such that, after implantation of said device, a dose of said active agent is caused to be released or released at an increased rate by compressing said active agent-delivery component, or by stretching said component, or by applying a torque to said component.

17. The device in accordance with claim 16 wherein said device is an inter-spinous process dynamic stabilization device, and wherein said device is configured such that, after implantation, compressive pressure, stretching or torque is exerted upon said active agent-delivery component by vertebral movement as a result of extension of the spinal column, flexion of the spinal column, bending of the spinal column or rotation of the spinal column.

18. The device in accordance with claim 16 wherein said device is an inter-transverse process dynamic stabilization device, and wherein said device is configured such that, after implantation, compressive pressure, stretching or torque is exerted upon said active agent-delivery component by vertebral movement as a result of extension of the spinal column, flexion of the spinal column, bending of the spinal column or rotation of the spinal column.

19. The device in accordance with claim 16 wherein said device is an anchor-based stabilization or fixation system, and wherein said device is configured such that, after implantation, compressive pressure, stretching or torque is exerted upon said active agent-delivery component by vertebral movement as a result of extension of the spinal column, flexion of the spinal column, bending of the spinal column or rotation of the spinal column.

20. An orthopedic implant device comprising an active agent-delivery component, wherein said active agent-delivery component comprises an elastic material having said active agent absorbed therein or adsorbed thereon, wherein said device is configured to release said active agent locally after said device is implanted in a patient, and wherein said device is configured such that a dose of said active agent is caused to be released or released at an increased rate by (a) compressing said active agent-delivery component, (b) stretching said component, or (c) by applying a torque to said component.

21. The device in accordance with claim 20 wherein said device is an anchor-based stabilization or fixation system.

22. The device in accordance with claim 20 wherein said device is a dynamic spinal stabilization device.

23. The device in accordance with claim 22 wherein said dynamic stabilization device is configured for placement between adjacent spinous processes, adjacent transverse processes or other posterior vertebral elements.

24. The device in accordance with claim 23 wherein said device is an inter-spinous process dynamic stabilization device.

25. The device in accordance with claim 24 wherein said device is configured such that, after implantation, compressive pressure, stretching or torque is exerted upon said active agent-delivery component by vertebral movement as a result of extension of the spinal column, flexion of the spinal column, bending of the spinal column or rotation of the spinal column, thereby causing said device to release a dose of said active agent or release a dose at an increased rate.

26. The device in accordance with claim 23 wherein said device is an anchor-based stabilization or fixation system.

27. The device in accordance with claim 23 wherein said device is an inter-transverse process dynamic stabilization device.

28. The device in accordance with claim 27 wherein said device is configured such that, after implantation, compressive pressure, stretching or torque is exerted upon said active agent-delivery component by vertebral movement as a result of extension of the spinal column, flexion of the spinal column, bending of the spinal column or rotation of the spinal column.

29. The device in accordance with claim 22 wherein said device comprises at least one structural component configured to provide dynamic spinal stabilization and at least one active agent-delivery component retained by said structural component.

30. The device in accordance with claim 22 wherein at least a portion of at least one of said structural components has the active agent impregnated therein or adsorbed thereon.

31. The device in accordance with claim 30 wherein said device comprises an internal structural component positioned within an outer sheath, and wherein said outer sheath comprises an absorbent or adsorbent or biodegradable material having said active agent impregnated therein or adsorbed thereon.

32. The device in accordance with claim 29 wherein said device comprises an internal structural component positioned within an outer sheath, and wherein said active agent-delivery component comprises an absorbent or adsorbent or biodegradable layer positioned between the internal structural component and the outer sheath.

33. The device in accordance with claim 29 wherein said device has an exterior surface and wherein said active agent-delivery component comprises an active agent-delivery layer affixed to at least a portion of said exterior surface.

34. The device in accordance with claim 29 wherein said at least one structural component defines at least one aperture and wherein said active agent-delivery component is an insert configured to be positioned in the aperture.

35. The device in accordance with claim 34 wherein said insert comprises a micromechanical machine.

36. The device in accordance with claim 22 wherein said active agent is selected from the group consisting of an anabolic agent, an anti-coagulant, an anti-infective agent, an anti-inflammatory agent, an anti-neoplastic agent, an anti-pyretic agent, an analgesic agent, an anti-spasmodic agent, an anti-thrombotic agent, an antihistamine, a biological, a bone morphogenetic protein, a diagnostic agent, a neuromuscular drug, a nutritional agent, a vasodilator, and a pro-drug.

37. The device in accordance with claim 22 wherein, after implantation of said device, said device releases said active agent in a sustained release manner.

38. An orthopedic implant device comprising a bone stabilization member positionable along adjacent bone portions outside an interspace between the bone portions, and an active agent-delivery component, wherein said device is configured to release said active agent locally after said device is implanted in a patient.

39. A method for delivering an active agent to a patient at a location adjacent an orthopedic implant device, comprising:

providing an orthopedic implant device comprising an active agent-delivery component, wherein the active agent-delivery component has an active agent impregnated therein or adsorbed thereon or otherwise contained therein and is configured to release the active agent locally after the device is implanted in a patient; and

surgically implanting the device in a posterior spinal location.

40. The method in accordance with claim 39 wherein the active agent-delivery component comprises an elastic material having the active agent absorbed therein or adsorbed thereon, and further comprising, after said implanting, causing a dose of the active agent to be released or released at an increased rate by (a) compressing the active agent-delivery component, (b) stretching the active agent-delivery component, or (c) by applying a torque to the active agent-delivery component.

41. The method in accordance with claim 39 wherein implant device comprises a posterior spinal fixation device or dynamic spinal stabilization device.